A Clinical Study to Evaluate the Efficacy and Safety of TQC2938 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
ACTIVE_NOT_RECRUITING
Status
Conditions
- Chronic Obstructive Pulmonary Disease
Interventions
- DRUG: TQC2938 injection
- DRUG: TQC2938 injection Placebo
Sponsor
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.